Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07251049 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing

Study acronym: EMAI-NGS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
: Encephalitis or myelitis is defined as the inflammatory or infectious involvement of the cerebral parenchyma or spinal cord. When an infectious origin is suspected, the germ is not always identified. Next-generation sequencing could be used to correct an etiological diagnosis of these severe conditions in Guadeloupe. The rate of cases for which the infectious agent is not identified encourages continued diagnostic efforts, with the objective of identifying new pathogens or emerging pathogens, some of which may be more specific in the tropics.
Trial Details
NCT Number NCT07251049
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions
(from sponsor)		 Acute Encephalitis, Acute Myelitis
Related terms Myelitis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov